(p)ppGpp and drug resistance

Journal of Cellular Physiology

Volumn 224, Issue 2, 2010, Pages 300-304

  Wu, Jun ^a   Long, Quanxin ^a   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; GUANOSINE 3' DIPHOSPHATE 5' DIPHOSPHATE; GUANOSINE 3' DIPHOSPHATE 5' TRIPHOSPHATE; MECILLINAM; MICROCIN J25; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN; RIFAMYCIN; RNA POLYMERASE; STREPTOLYDIGIN; VANCOMYCIN; BETA LACTAM;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL DEATH; CELL WALL; DRUG DESIGN; DRUG EFFICACY; DRUG TARGETING; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; SHORT SURVEY; STAPHYLOCOCCUS INFECTION; SYPHILIS; TRANSCRIPTION INITIATION; TUBERCULOSIS; TYPHOID FEVER; URINARY TRACT INFECTION; ARTICLE; CHEMISTRY; DRUG RESISTANCE; METABOLISM;

BETA-LACTAMS; DRUG RESISTANCE; DRUG RESISTANCE, MICROBIAL; GUANOSINE PENTAPHOSPHATE;

EID: 77953631468     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22158     Document Type: Short Survey

References (50)

1. Abranches J, Martinez AR, Kajfasz JK, Chavez V, Garsin DA, Lemos JA. 2009. The molecular alarmone (p)ppGpp mediates stress responses, vancomycin tolerance, and virulence in Enterococcus faecalis. J Bacteriol 191:2248-2256.
2. Artsimovitch I, Patlan V, Sekine S, Vassylyeva MN, Hosaka T, Ochi K, Yokoyama S, Vassylyev DG. 2004. Structural basis for transcription regulation by alarmone ppGpp. Cell 117:299-310.
3. Bayro MJ, Mukhopadhyay J, Swapna GV, Huang JY, Ma LC, Sineva E, Dawson PE, Montelione GT, Ebright RH. 2003. Structure of antibacterial peptide microcin J25: A 21-residue lariat protoknot. J Am Chem Soc 125:12382-12383.
4. Betzner AS, Ferreira LC, Holtje JV, Keck W. 1990. Control of the activity of the soluble lytic transglycosylase by the stringent response in Escherichia coli. FEMS Microbiol Lett 55:161-164.
5. Bouloc P, Vinella D, D'Ari R. 1992. Leucine and serine induce mecillinam resistance in Escherichia coli. Mol Gen Genet 235:242-246.
6. Brown MR, Williams P. 1985. The influence of environment on envelope properties affecting survival of bacteria in infections. Annu Rev Microbiol 39:527-556.
7. Clarke PD, Geddes AM, McGhie D, Wall JC. 1976. Mecillinam: A new antibiotic for enteric fever. Br Med J 2:5-14.
8. Dahl JL, Kraus CN, Boshoff HI, Doan B, Foley K, Avarbock D, Kaplan G, Mizrahi V, Rubin H, Barry CE 3rd. 2003. The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. ProcNatl Acad Sci USA 100:10026-10031.
9. Durfee T, Hansen AM, Zhi H, Blattner FR, Jin DJ. 2008. Transcription profiling of the stringent response in Escherichia coli. J Bacteriol 190:1084-1096.
10. Eymann C, Homuth G, Scharf C, Hecker M. 2002. Bacillus subtilis functional genomics: Global characterization of the stringent response by proteome and transcriptome analysis. J Bacteriol 184:2500-2520.
11. Ezequiel W, Jehoshua K, Gad G, Roee V. 2008. ppGpp analogues as antibacterial compounds. Nucleic Acids Symp Ser (Oxf) 52:633-634.
12. Geddes AM, Clarke PD. 1977. The treatment of enteric fever with mecillinam. J Antimicrob Chemother 3:101-102.
13. Geraci JE,Wilson WR. 1981. Vancomycin therapy for infective endocarditis. Rev Infect Dis 3:S250-S258.
14. Greenway DL, England RR. 1999. The intrinsic resistance of Escherichia coli to various antimicrobial agents requires ppGpp and sigma s. Lett Appl Microbiol 29:323-326.
15. Hammer BK, Tateda ES, Swanson MS. 2002. A two-component regulator induces the transmission phenotype of stationary-phase Legionella pneumophila. Mol Microbiol 44:107-118.
16. Haralalka S, Nandi S, Bhadra RK. 2003. Mutation in the relA gene of Vibrio cholerae affects in vitro and in vivo expression of virulence factors. J Bacteriol 185:4672-4682.
17. Heath RJ, Jackowski S, Rock CO. 1994. Guanosine tetraphosphate inhibition of fatty acid and phospholipid synthesis in Escherichia coli is relieved by overexpression of glycerol-3-phosphate acyltransferase (plsB). J Biol Chem 269:26584-26590.
18. Hesketh A, Chen WJ, Ryding J, Chang S, Bibb M. 2007. The global role of ppGpp synthesis in morphological differentiation and antibiotic production in Streptomyces coelicolor A3(2). Genome Biol 8:R161.
19. Kwon NY, Kim JD, Pai HJ. 2002. The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii. Korean J Intern Med 17:94-99.
20. Landgraf JR, Wu J, Calvo JM. 1996. Effects of nutrition and growth rate on Lrp levels in Escherichia coli. J Bacteriol 178:6930-6936.
21. Lemos JA, Lin VK, Nascimento MM, Abranches J, Burne RA. 2007. Three gene products govern (p)ppGpp production by Streptococcus mutans. Mol Microbiol 65:1568-1581.
22. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 10:S122-S129.
23. Lueking DR, Goldfine H. 1975. The involvement of guanosine 5-diphosphate-3-diphosphate in the regulation of phospholipid biosynthesis in Escherichia coli. Lack of ppGpp inhibition of acyltransfer from acyl-ACP to sn-glycerol 3-phosphate. J Biol Chem 250:4911-4917.
24. Ma D, Cook DN, Hearst JE, Nikaido H. 1994. Efflux pumps and drug resistance in gramnegative bacteria. Trends Microbiol 2:489-493.
25. Macvanin M, Hughes D. 2005. Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics. FEMS Microbiol Lett 247:215-220.
26. Merlie JP, Pizer LI. 1973. Regulation of phospholipid synthesis in Escherichia coli by guanosine tetraphosphate. J Bacteriol 116:355-366.
27. Mukhopadhyay J, Sineva E, Knight J, Levy RM, Ebright RH. 2004. Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. Mol Cell 14:739-751.
28. Mukhopadhyay J, DasK, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R, Irschik H, Arnold E, Ebright RH. 2008. The RNA polymerase "switch region" is a target for inhibitors. Cell 135:295-307.
29. Na HS, Kim HJ, Lee HC, Hong Y, Rhee JH, Choy HE. 2006. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis. Vaccine 24:2027-2034.
30. Nakanishi N, Abe H, Ogura Y, Hayashi T, Tashiro K, Kuhara S, Sugimoto N, Tobe T. 2006. ppGpp with DksA controls gene expression in the locus of enterocyte effacement (LEE) pathogenicity island of enterohaemorrhagic Escherichia coli through activation of two virulence regulatory genes. Mol Microbiol 61:194-205.
31. Nanamiya H, Kasai K, Nozawa A, Yun CS, Narisawa T, Murakami K, Natori Y, Kawamura F, Tozawa Y. 2008. Identification and functional analysis of novel (p)ppGpp synthetase genes in Bacillus subtilis. Mol Microbiol 67:291-304.
32. Neu HC. 1985. Amdinocillin: A novel penicillin. Antibacterial activity, pharmacology and clinical use. Pharmacotherapy 5:1-10.
33. Pham P, Bartlett JG. 2008. Amdinocillin (mecillinam). Point-of-Care Information Technology ABX Guide. (http://prod.hopkins-abxguide.org/antibiotics/ antibacterial/pcn-others/amdinocillin--mecillinam-.html?)
34. Pisabarro AG, de Pedro MA, Vazquez D. 1985. Structural modifications in the peptidoglycan of Escherichia coli associated with changes in the state of growth of the culture. J Bacteriol 161:238-242.
35. Pizarro-Cerda J, Tedin K. 2004. The bacterial signal molecule, ppGpp, regulates Salmonella virulence gene expression. Mol Microbiol 52:1827-1844.
36. Playfair, Roitt, Wakelin & Williams (Eds). 1993. Medical Microbiology Mims, Mosby Year Book Europe Ltd. ISBN 0 397 44631 4.
37. Pomares MF, Vincent PA, Farias RN, Salomon RA. 2008. Protective action of ppGpp in microcin J25-sensitive strains. J Bacteriol 190:4328-4334.
38. Potrykus K, Cashel M. 2008. (p)ppGpp: Still magical? Annu Rev Microbiol 62:35-51.
39. Quintiliani R, Jr., Courvalin P. 1995. Mechanisms of resistance to antimicrobial agents. Manual of clinical microbiology, 6th edition. Washington, DC: ASM Press. p 1319.
40. Ray TK, Cronan JE, Jr. 1975. Acylation of sn-glycerol 3-phosphate in Escherichia coli. Study of reaction with native palmitoyl-acyl carrier protein. J Biol Chem 250:8422-8427.
41. Rodionov DG, Ishiguro EE. 1995. Direct correlation between overproduction of guanosine 3′,5′-bispyrophosphate (ppGpp) and penicillin tolerance in Escherichia coli. J Bacteriol 177:4224-4229.
42. Rosengren KJ, Clark RJ, Daly NL, Goransson U, Jones A, Craik DJ. 2003. Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. J Am Chem Soc 125:12464-12474.
43. Socias SB, Vincent PA, Salomon RA. 2009. The leucine-responsive regulatory protein, Lrp, modulatesmicrocin J25 intrinsic resistance in Escherichia coli by regulating expression of the YojI microcin exporter. J Bacteriol 191:1343-1348.
44. Solbiati JO, Ciaccio M, Farias RN, Gonzalez-Pastor JE, Moreno F, Salomon RA. 1999. Sequence analysis of the four plasmid genes required to produce the circular peptide antibiotic microcin J25. J Bacteriol 181:2659-2662.
45. Spratt BG, Pardee AB. 1975. Penicillin-binding protein and cell shape in E. coli. Nature (Lond) 254:515-517.
46. Swenson JM, Facklam RR, Thornsberry C. 1990. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother 34:543-549.
47. Taylor CM, Beresford M, Epton HAS, Sigee DC, Shama G, Andrew PW, Roberts IS. 2002. Listeria monocytogenes relA and hpt mutants are impaired in surface-attached growth and virulence. J Bacteriol 184:621-628.
48. Viducic D, Ono T, Murakami K, Susilowati H, Kayama S,Hirota K,Miyake Y. 2006. Functional analysis of spoT, relA and dksA genes on quinolone tolerance in Pseudomonas aeruginosa under nongrowing condition. Microbiol Immunol 50:349-357.
49. Vinella D, D'Ari R, Jaffe A, Bouloc P. 1992. Penicillin binding protein 2 is dispensable in Escherichia coli when ppGpp synthesis is induced. EMBO J 11:1493-1501.
50. Wright NE, Gilbert P. 1987. Influence of specific growth rate and nutrient limitation upon the sensitivity of Escherichia coli towards chlorhexidine diacetate. J Appl Bacteriol 62:309-314.